about
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients ...
Read More
4.21
0.24
(6.05%)
118.2K
XNAS Volume
XNAS 22 Dec, 2025 1:50 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Cingulate Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..